Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Weight Watchers International, Inc. (WTW), NutriSystem Inc. (NTRI), Medifast, Inc. (MED): Three Weight Loss Companies Just Got A Huge Boost

Page 1 of 2

Up until now, weight loss was a personal issue and social stigma. That’s all about to change since the American Medical Association (AMA) has voted to recognize obesity as a disease. This is going to be a huge long-term boost to Weight Watchers International, Inc. (NYSE:WTW), NutriSystem Inc. (NASDAQ:NTRI), and Medifast, Inc. (NYSE:MED).

Weight Watchers International, Inc. (NYSE:WTW)

Getting Care

Obesity has long been an issue associated with an inability to control one’s habits. Eating right and exercise were the generally accepted solution to the problem. However, for many people, the ability to follow a healthier routine is just too difficult.

Being overweight leads to many ills, including diabetes. Such complications, though, are not certain and take time to develop, so there’s often no impetus to deal with weight right away. However, once a health condition like diabetes is diagnosed, dealing with the problem is expensive and life altering in a not so positive way.

To get ahead of such medical issues, the AMA has decided to label obesity as a disease. That will allow it to be treated earlier, make people take excessive weight gain more seriously, and likely lead to third party payments. That last one is a huge opportunity for companies dealing with weight loss.

The Leader in the Space

Weight Watchers International, Inc. (NYSE:WTW) is a global giant in the weight loss business. The key to its success is building communities that provide mutual support on a common goal. This differentiates its business model and makes customers very loyal. The company’s brand is well known and it has a massive store base, which furthers the appeal.

The company doesn’t try to directly control a customer’s food intake, instead focusing on teaching people how to eat using a point system. That said, the brand is so strong that Weight Watchers International, Inc. (NYSE:WTW) has been able to partner with restaurants and food processors to give its “seal of approval” to select foods.

Because Weight Watchers International, Inc. (NYSE:WTW)’ business model is group based, it would be very easy for third party payers to participate. Weight Watchers could simply track attendance or set up groups within corporate settings for a fee. Either one could materially increase the company’s customer base.

Sales and earnings dipped during the 2007 to 2009 recession, but have been headed higher since. The dividend was recently increased, as well. With a trailing price to earnings ratio of about 10, the shares are relatively cheap. The AMA’s aggressive stance on obesity could be the catalyst needed to push the top and bottom lines higher.

Cooking for You

NurtiSystem takes a different approach to weight loss. It designs and sells meal plans, taking over the food choice decision from its customers. That’s an expensive proposition, however, and the recession wasn’t kind to discretionary spending. Sales have fallen every year since 2007. Earnings dipped into the red last year.

That’s not a particularly appealing portrait. However, if obesity is a disease, then a medical treatment can be prescribed. Since some people clearly have difficulty controlling their eating habits, NutriSystem Inc. (NASDAQ:NTRI) is an obvious and easy solution. Adding to the appeal here is that the company has meal plans designed specifically for diabetics. That gives it a chance to serve both the obesity and diabetic markets.

This is a high-risk turnaround play. That said, the company has no long-term debt and $35 million in cash, as of the first quarter. The AMA ruling could mark an important turning point.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!